‘The Pfizer-BioNTech study will be run in the US, Europe, S America and Africa and focuses on the third trimester of pregnancy to minimise risk to unborn children’
Julie Steenhuysen, Michael Erman
(Adds Pfizer interview, trial details)
CHICAGO, Feb 18 (Reuters) - Pfizer Inc and BioNTech SE have started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women, the companies said on Thursday.
Pregnant women are at higher risk of developing severe COVID-19, and many public health officials have recommended some women in high-risk professions take coronavirus vaccines even without proof they are safe for them.
Dr. William Gruber, senior vice president of vaccine clinical research and development for Pfizer, said in an interview the company could have results by the fourth quarter of 2021.
Pfizer and BioNTech Drugmakers Start Vaccine Trials on Pregnant Women - Novinite com novinite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from novinite.com Daily Mail and Mail on Sunday newspapers.
Pfizer and BioNtech have started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women, the companies said on Thursday.